A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes

Antonia Ceccarelli1, Maria A Rocca, Elisabetta Pagani

  • 1Neuroimaging Research Unit, Scientific Institute and University Ospedale San Raffaele, Milan, Italy.

Neuroimage
|May 27, 2008
PubMed

Insights

Grey matter loss in multiple sclerosis (MS) varies by clinical phenotype, with progressive forms showing more significant changes. Lesion volume strongly correlates with regional grey matter loss across all MS types.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Grey matter (GM) atrophy is a key feature of MS pathology, contributing to disability.
  • Understanding regional GM changes across different MS phenotypes is crucial for prognosis and treatment.

Purpose of the Study:

  • To investigate regional grey matter (GM) volume differences in patients with multiple sclerosis (MS) across various clinical phenotypes.
  • To correlate these GM changes with T2 lesion volumes (LV) using voxel-based morphometry (VBM).
  • To differentiate GM loss patterns between clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), secondary progressive MS (SPMS), and primary progressive MS (PPMS).

Main Methods:

  • Conventional MRI scans were acquired from 71 MS patients (26 RRMS, 27 SPMS, 18 PPMS), 28 CIS patients, and 21 controls.
  • Voxel-based morphometry (VBM) was employed to assess regional grey matter (GM) changes.
  • Correlation analysis was performed between GM volumes and T2 lesion volumes (LV).

Main Results:

  • No GM loss was observed in CIS patients compared to controls.
  • RRMS patients showed GM loss in the right pre- and postcentral gyri compared to CIS.
  • SPMS patients exhibited significant GM loss in widespread brain regions, cerebellum, and deep GM structures compared to RRMS.
  • PPMS patients showed GM loss in specific cortical and subcortical areas compared to SPMS.
  • Regional GM loss strongly correlated with brain T2 LV in all MS groups, with regional correlations observed in SPMS and PPMS.

Conclusions:

  • Grey matter volume loss in MS follows distinct regional patterns based on clinical phenotype.
  • GM atrophy is likely secondary to white matter inflammatory-demyelinating lesions.
  • Progressive forms of MS (SPMS and PPMS) demonstrate more pronounced and widespread GM loss.
  • The extent and location of T2 lesions are significantly associated with regional GM atrophy.

Related Concept Videos

Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...